GlassScriptPhysician profile
Joseph J Ross
NPI 1780602482
$3,394.34
in general payments reported to CMS, 2019-2025
19 companies · $518 in 2025
The $518 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $298 · 2020: $464 · 2021: $629 · 2022: $687 · 2023: $547 · 2024: $252 · 2025: $518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,317.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $1,459.20 | 2019-2023 | Tepezza |
| Abbvie INC. | $609.89 | 2022-2025 | Durysta |
| Alcon Vision LLC | $383.69 | 2019-2025 | Rocklatan, Argos |
| Bausch & Lomb Americas INC. | $253.79 | 2022-2025 | Miebo, Xiidra |
| Allergan, INC. | $134.73 | 2021-2022 | |
| Aerie Pharmaceuticals, INC. | $107.02 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $92.73 | 2019-2023 | Cequa |
| Novartis Pharmaceuticals Corporation | $65.77 | 2020-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $50.65 | 2024 | |
| Alimera Sciences, INC. | $43.47 | 2020 | |
| Dompe US, INC. | $30.78 | 2025 | Oxervate |
| Tearlab Corp | $29.18 | 2021-2022 | |
| Thrombogenics, INC. | $22.47 | 2019 | |
| Mauna Kea Technologies, INC. | $22.34 | 2025 | |
| Biotissue Holdings INC. | $19.51 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Notal Vision, INC. | $17.66 | 2024 | Foresee Home |
| Carl Zeiss Meditec, INC. | $16.12 | 2020 | |
| Eyevance Pharmaceuticals LLC | $15.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.